Skip Navigation



Annals of Oncology Advance Access published online on April 20, 2006
Annals of Oncology, doi:10.1093/annonc/mdl052
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
17/9/1465    most recent
mdl052v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Altundag, K.
Right arrow Articles by Baptista, M. Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Altundag, K.
Right arrow Articles by Baptista, M. Z.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2006 European Society for Medical Oncology

letter to the editor

Promotion of neurogenesis by human stem cells in high-risk breast cancer survivals after stem-cell supported high-dose therapy

K. Altundag 1 *, C. D. Moussallem 2, and M. Z. Baptista 3

1 Department of Medical Oncology, Hacettepe University Institute of Oncology Ankara, Turkey
2 Department of Internal Medicine, Beirut Governmental University Hospital, Beirut, Lebanon
3 Department of Clinical Oncology, Hospital Maternidade De Campinas, Campinas, SP, Brazil

* To whom correspondence should be addressed.
K. Altundag, E-mail: drkadri{at}usa.net



This article has no Abstract.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Ann OncolHome page
A Scherwath
Reply to 'Promotion of neurogenesis by human stem cells in high-risk breast cancer survivals after stem-cell supported high-dose therapy' by K. Altundag et al. (Ann Oncol 2006; 17: 1465)
Ann. Onc., September 1, 2006; 17(9): 1465 - 1466.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.